Stifel Nicolaus Sticks to Its Buy Rating for IGM Biosciences (IGMS)
TipRanksApr 19 02:25
Analysts' Opinions Are Mixed on These Healthcare Stocks: IGM Biosciences (IGMS) and Argenx Se (ARGX)
TipRanksApr 18 18:30
IGM Biosciences Analyst Ratings
BenzingaApr 18 18:32
Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Alpine Immune Sciences (ALPN) and IGM Biosciences (IGMS)
TipRanksMar 19 20:50
IGM Biosciences Analyst Ratings
BenzingaMar 12 18:44
IGM Biosciences: A Balanced Hold Rating Amid Financial Stability and Drug Development Risks
TipRanksMar 12 18:27
IGM Biosciences Analyst Ratings
BenzingaMar 8 23:09
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), IGM Biosciences (IGMS) and Optinose (OPTN)
TipRanksMar 8 22:01
Analysts' Top Healthcare Picks: Inventiva (IVA), IGM Biosciences (IGMS)
TipRanksMar 8 21:30
RBC Capital Sticks to Their Buy Rating for IGM Biosciences (IGMS)
TipRanksMar 8 20:27
IGM Biosciences Analyst Ratings
BenzingaFeb 9 23:31
IGM Biosciences Shares Upgraded to Outperform on $1B+ Long-term Opportunity
InvestingFeb 9 21:58
RBC Upgrades IGM Biosciences to Outperform From Sector Perform, Boosts Price Target to $21 From $9; Speculative Risk Kept
MT NewswiresFeb 9 20:33
B of A Securities Downgrades IGM Biosciences to Neutral, Announces $8 Price Target
BenzingaDec 15, 2023 21:39
IGM Biosciences Analyst Ratings
BenzingaDec 15, 2023 21:38
HC Wainwright & Co. Downgrades IGM Biosciences to Neutral, Lowers Price Target to $7
BenzingaDec 8, 2023 00:10
IGM Biosciences Analyst Ratings
BenzingaDec 8, 2023 00:07
IGM Biosciences Analyst Ratings
BenzingaDec 6, 2023 23:49
RBC Raises Price Target on IGM Biosciences to $9 From $8 on Reduced Ancillary Spend Amid Job Cuts, Keeps Sector Perform, Speculative Risk
MT NewswiresDec 6, 2023 20:59
IGM Biosciences Analyst Ratings
BenzingaNov 15, 2023 22:31
No Data
No Data